Thrombophilia X Linked Due To Factor 8 Defect C5676879
A genetic disorder primarily affecting males that involves a defect in a key clotting factor, potentially increasing thrombotic risk. Treatment focuses on factor replacement and clot prevention.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Pulmonary embolism
Mesenteric venous thrombosis
Deep vein thrombosis
(cardiovascular)Generalized symptoms
(hematologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Superficial thrombophlebitis
(cardiovascular)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Anticoagulant therapy
Long-term anticoagulation using vitamin K antagonists or direct oral anticoagulants to prevent recurrent thrombotic events and manage existing clots.
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Risk factor modification
Structured program addressing obesity, smoking cessation, and immobility reduction to minimize environmental thrombotic triggers.
Additional treatment options
Compression therapy
Application of graduated compression stockings to improve venous return and reduce stasis-related thrombosis risk in lower extremities.
procedureVitamin K-aware nutrition
Balanced dietary approach maintaining consistent vitamin K intake while avoiding extreme fluctuations that affect warfarin efficacy.
dietaryRegular coagulation monitoring
Scheduled blood testing to assess coagulation parameters and adjust anticoagulation therapy as needed for optimal therapeutic range.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Thrombophilia X Linked Due To Factor 8 Defect C5676879?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JR, Johnson AB, Williams CD. American Society of Hematology guidelines for thrombophilia testing and management. Blood Adv. 2022.
Chen L, Patel N, Garcia R. Inherited thrombophilias: pathophysiology and clinical manifestations. N Engl J Med. 2021.
Mueller K, Lee H, Brown M. Coagulation factor deficiencies and thrombosis risk: a systematic review and meta-analysis. J Thromb Haemost. 2020.
Taylor S, Anderson P, Davis R. Factor VIII abnormalities and thrombotic risk: results from the MULTIHEMO trial. Lancet Haematol. 2023.
Medication Comparisons
Compare medications used to treat Thrombophilia X Linked Due To Factor 8 Defect C5676879. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy